.
3692 financial statements
* Numbers in millions
Year |
2019 | 2020 | TTM |
---|---|---|---|
Capitalization * |
150 631 | 249 153 | 88 379 |
EV * |
142 402 | 244 961 | 244 961 |
Stock price ¤ |
27.5 | 42.4 | 15.04 |
Number of shares * |
5 477 | 5 876 | 5 876 |
EPS |
0,47 | 0,44 | 0,44 |
Revenue * |
8 683 | 8 690 | 8 690 |
Net income * |
2 557 | 2 569 | 2 569 |
Operating profit * |
2 822 | 2 830 | 2 830 |
Total liabilities * |
6 531 | 2 916 | 2 916 |
Net debt * |
-8 229 | -4 192 | -4 192 |
Total assets * |
19 575 | 20 792 | 20 792 |
Equity * |
13 044 | 17 876 | 17 876 |
Cash and investments * |
14 594 | 13 718 | 13 718 |
Over the past 10 years, the maximum capitalization of Hansoh Pharmaceutical Group Company Limited is 249 153, the minimum is 150 631. Maximum net income 2 569, Minimum net income 2 557. The maximum price of 3692 shares is 42.4, the minimum price is 27.5.
.
3692 valuation
Year |
2019 | 2020 | TTM |
---|---|---|---|
P/E |
58,92 | 96,99 | 34,40 |
P/B |
11,55 | 13,94 | 4,94 |
P/S |
17,35 | 28,67 | 10,17 |
E/P |
2% | 1% | 3% |
P/FCF |
55,13 | 261,93 | 92,91 |
.
3692 profitability
Year |
2019 | 2020 | TTM |
---|---|---|---|
ROE |
20% | 14% | |
ROA |
13% | 12% | |
ROIC |
21% | 16% |